3 exciting ASX shares you won’t want to miss out on

Finding ASX shares that can genuinely scale over time is not always easy.

A lot of companies talk about big opportunities, but only a handful actually build the foundations needed to turn that potential into long-term growth. 

I think the most compelling opportunities tend to have strong platforms, expanding markets, and clear ways to grow beyond where they are today.

Here are three ASX shares I think fit that description right now:

SiteMinder Ltd (ASX: SDR)

SiteMinder has built a global platform that sits at the centre of hotel bookings and distribution.

What I like about this business is that it is not just growing by adding more customers. It is also increasing how much revenue it earns from each customer through additional products and services.

As the travel industry becomes more complex, hotels need better tools to manage pricing, distribution, and demand across multiple channels. SiteMinder is positioning itself as that core infrastructure layer.

I think the long-term opportunity here comes from deeper monetisation. If the company continues to expand its product suite and increase adoption across its customer base, revenue can grow even without a dramatic increase in customer numbers.

Megaport Ltd (ASX: MP1)

Megaport is building a global network platform that connects businesses to cloud providers, data centres, and increasingly, compute services.

The key attraction for me is how this business is evolving alongside major technology trends. As cloud usage grows and artificial intelligence (AI) drives greater demand for data and processing, the need for fast, flexible connectivity is only increasing.

Megaport’s platform enables customers to scale their network connections on demand, making it a valuable piece of infrastructure in a more digital, data-heavy world.

I also think the company’s expansion into compute services adds another layer to the story. It opens up a larger addressable market and gives Megaport more ways to grow over time.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix offers something different to the typical technology-focused ASX growth share.

The company operates in radiopharmaceuticals, developing imaging and therapeutic products for cancer. It already has a commercial product in market, which helps support ongoing growth and investment into its pipeline.

What stands out to me is the potential for multiple products to drive future revenue. If the company continues to successfully develop and commercialise new treatments, it could build a broader portfolio over time.

This is not without risk, as healthcare companies depend on clinical success and regulatory approvals. But the upside can be significant when things go right.

Foolish Takeaway

All three of these ASX shares are growing in different ways, but they share one important characteristic.

They are building platforms that can expand over time. SiteMinder is deepening its role in hotel commerce, Megaport is connecting the infrastructure behind the digital economy, and Telix is working towards a broader portfolio of healthcare products.

That combination of scale, opportunity, and optionality is what makes them exciting to me.

The post 3 exciting ASX shares you won’t want to miss out on appeared first on The Motley Fool Australia.

More reading

• Up 68% from a multi-year low. Are Telix shares a buy, sell or hold?
• 3 ASX 200 shares tipped to rise 20% or more
• These are the 10 most shorted ASX shares
• ASX 200 tech shares rocket 13% as long-awaited sector rebound accelerates
• The tech rally is back: here are 5 ASX shares leading the charge

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport, SiteMinder, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended SiteMinder. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.